XCath EVR (robot surgeon)

2025: Product Announcement

In mid-November 2025, Houston-based US company XCath announced the release of the EVR robotic surgical platform for intracranial interventions. The system is already being used to treat patients with complex brain aneurysms.

An aneurysm is a pathological dilation or protrusion of the wall of a blood vessel due to its thinning. This condition can remain asymptomatic for a long time. However, under certain conditions, an aneurysm can burst and cause abundant internal hemorrhage, leading to hemorrhagic stroke, severe neurological disorders or death. There are different treatments for pathology, including surgical clipping and endovascular embolization.

𝓲

Фото: XCath

The EVR robotic platform is compatible with various conductors, catheters and other therapeutic devices. Control is carried out through a special console. XCath claims that the complex allows you to manipulate with the highest accuracy. This reduces the burden on surgeons and minimizes errors associated with the human factor.

The first operations using the EVR surgical system were successfully performed in Panama. During the procedures, as noted, surgeons used commercially available stents that divert blood flow, as well as standard endovascular devices.

"The successful execution of these operations marks an important milestone in the world of endovascular robotics. The possibility of such complex interventions using robotic platforms could revolutionize the treatment of patients with aneurysms and strokes, "says Dr. Fred Moll, who is considered the" father of surgical robotics^[1]

Notes